Objective: Normal adipose tissue growth and function is critical to maintaining metabolic homeostasis and its excess (e.g. obesity) or absence (e.g. lipodystrophy) is associated with severe metabolic disease. The goal of this study was to understand the mechanisms maintaining healthy adipose tissue growth and function. Methods: Adipose tissue senses and responds to systemic changes in growth factor and nutrient availability; in cells mTORC1 regulates metabolism in response to growth factors and nutrients. Thus, mTORC1 is poised to be a critical intracellular regulator of adipocyte metabolism. Here, we investigate the role of mTORC1 in mature adipocytes by generating and characterizing mice in which the Adiponectin-Cre driver is used to delete floxed alleles of Raptor, which encodes an essential regulatory subunit of mTORC1.
INTRODUCTION
White adipose tissue (WAT) functions both as the body's major energy storage site, and as a critical endocrine tissue, and interest in understanding its biology has intensified with the obesity epidemic. Obesity (defined as a BMI > 30) results from energy imbalance and can lead to ectopic lipid deposition in non-adipose tissues (e.g. the liver), type 2 diabetes, cardiovascular disease, and some cancers. Obesity now affects more than 1 in 3 adults in the United States, and between 8% and 25% of adults in countries of the European Union, making this a major international clinical problem of this era [1e3] . Lack of adipose tissue or lipodystrophy also associates with severe metabolic complications. For example, patients suffering from congenital generalized lipodystrophy (or Berardinelli-Seip Syndrome) also develop insulin resistance, hypertriglyceridemia, and fatty liver disease, which can lead to hepatomegaly and liver failure. Thus, normal adipose tissue growth and function is critical to maintaining metabolic homeostasis and understanding the mechanisms that promote healthy fat has broad clinical implications.
The mechanistic target of rapamycin complex 1 (mTORC1) integrates multiple upstream signals from nutrient availability to promote anabolic metabolism. For example, mTORC1 detects intracellular amino acid availability through multiple sensors that converge upon the Rag GTPases to control mTORC1 subcellular localization, and circulating glucose levels through the insulin-signaling pathway, which promotes mTORC1 activity through the TSC/Rheb pathway [4e6] . Thus, mTORC1 is poised to be a critical regulator of adipocyte function. To test this, we conditionally deleted the essential mTORC1 regulatory subunit Raptor in mature adipocytes with Adiponectin-Cre, which is reported to have greater efficiency and specificity for mature adipocytes than aP2-Cre [7e11]. We find that Raptor Adipoq-Cre mice have normal WAT mass for the first few weeks of life, but progressively develop a lipodystrophy disorder resembling human congenital generalized lipodystrophy including insulin intolerance and hepatic steatosis. These and several additional characteristics of the Raptor Adipoq-Cre mice differ significantly from those of mice in which Raptor was deleted with aP2-Cre [12] . Our results provide a new framework for understanding how mTORC1 signaling helps maintain healthy adipose tissue and could provide insight into human lipodystrophy disorders.
MATERIALS & METHODS

Mice
Raptor floxed mice are described in [13] and were backcrossed 10 generations to C57BL/6 and crossed to mice expressing the Adiponectin-Cre driver or the Ucp1-Cre driver (generous gifts of Evan Rosen). Floxed Cre-negative mice were used as controls. Mice were kept on a daily 12 
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Tissue samples or cells were lysed in a buffer containing 50 mM Hepes, pH 7.4, 40 mM NaCl, 2 mM EDTA, 1.5 mM NaVO4, 50 mM NaF, 10 mM sodium pyrophosphate, 10 mM sodium b-glycerophosphate and 1% Triton X-100. Tissues were homogenized using a TissueLyser (Qiagen) in the same lysis buffer supplemented with 0.1% SDS, 1% sodium deoxycholate. Equal amounts of total protein were loaded into acrylamide/bis-acrylamide gels and transferred to PVDF membranes for detection with the indicated antibodies. Membranes were incubated with primary antibodies in 5% milk/PBST or 5% BSA/PBST overnight. Membranes were then incubated for 1hr with HRP-conjugated secondary antibodies. Western blots were developed by enhanced chemiluminescence (PerkinElmer) and detected by X-ray films. To obtain UCP1 signaling from WAT lysates, films were exposed for varying durations, up to 12 hrs for the indicated "long exposure (LE)". 
RESULTS AND DISCUSSION
3.1. Adipocyte Raptor KO mice have normal WAT mass early in life To investigate the role of mTORC1 in adipocytes, we generated Adiponectin-Cre;Raptor fl/fl mice (herein Raptor Adipoq-cre mice). RaptorAdipoq-cre mice are born at the expected Mendelian ratio and are grossly indistinguishable from their littermates at birth. At post-natal day 14 (P14), there is no difference in total body weight between control and Raptor Adipoq-cre mice ( Figure 1A ). The major subcutaneous and visceral perigonadal white adipose tissue depots (sWAT and pgWAT) are not significantly different in mass from controls at P14 ( Figure 1B) . Liver mass at P14 is also not significantly different though it is trending slightly larger in the KOs; the mass of other lean tissues such as the heart, kidney, and skeletal muscle is normal ( Figure 1C ). We confirmed Raptor loss by Western blots using whole sWAT and interscapular brown adipose tissue (iBAT) depots ( Figure 1D) ; the residual signal reflects the non-adipocyte population (see Section 3.2). Inactivation of mTORC1 activity was confirmed by decreased phosphorylation of the mTORC1 substrates 4E-BP1 (on phospho-T37/46) and ULK1 (on phospho-S757), and by increased phosphorylation of AKT (on phospho-S473), which is caused by loss of the well-known mTORC1-mediated feedback inhibition of insulin/AKT signaling ( Figure 1D ) [4] . We also noted a slight decrease in total ULK1 protein in the KO tissues ( Figure 1D ). In post-natal development, the sWAT adipocytes exhibit characteristics of brown adipocytes including the presence of multi-locular lipid droplets and positive UCP1 expression ( Figure 1D ,E) [14, 15] . These adipocytes are called brite or beige adipocytes to distinguish them from classic brown adipocytes [16] , and with age, they usually convert to or are replaced by more classic-looking unilocular white adipocytes. Raptor Adipoq-cre mice exhibit no defect in the post-natal formation of brite/beige adipocytes in the sWAT as determined by UCP1 protein expression ( Figure 1D ) and the appearance of multilocular adipocytes ( Figure 1E ). There is also no difference in the histological appearance of the pgWAT adipocytes or the liver at P14 ( Figure 1E ). Thus, Raptor is dispensable in white adipocytes for post-natal adipose tissue growth and normal adipocyte size, and for post-natal formation of brite/beige adipocytes in the sWAT. In contrast, the interscapular and subscapular brown adipose tissue depots (iBAT and sBAT) of Raptor Adipoq-cre mice are reduced in mass by 37% and 48% respectively at P14 ( Figure 1B) . We also noted an increase in the number of brown adipocytes containing large lipid droplets in the Raptor KO BAT ( Figure 1F ). To test whether this phenotype is tissue autonomous, we deleted Raptor with Ucp1-Cre. This also results in a significant size reduction of the BAT depots ( Figure S1A ) and the heterogeneous appearance of larger lipid droplets ( Figure S1B ). Total body mass and individual WAT depot mass was normal in Raptor Ucp1-Cre mice ( Figure S1CeD ). Thus, while adipocyte Raptor is dispensable for post-natal WAT growth, it is required autonomously in brown adipocytes for normal post-natal BAT growth and lipid droplet size. 3.2. Adipocyte Raptor KO mice progressively develop lipodystrophy associated with hepatic steatosis and insulin intolerance During the first 4 months of life, Raptor Adipoq-cre mice consuming a normal chow diet (NCD) tend to be slightly heavier than controls although this does not reach statistical significance at least by 12 weeks of age (p value ¼ 0.066) (Figure 2A, left) . Raptor Adipoq-cre mice also tend to eat slightly more food but again this was not statistically significant (p value ¼ 0.25) (Figure 2A, right) . However, despite their relatively normal body weight, Raptor Adipoq-cre mice fail to expand their white adipose tissues with age. For example, the KO sWAT, retroperitoneal WAT (rWAT) and pgWAT are 35%, 37%, and 54% smaller respectively in the KOs compared to age matched controls ( Figure 2B,C) ; KO BAT tissues also remained small ( Figure 2B,C) . Thus, adipocyte Raptor KO mice progressively develop lipodystrophy with age. We also confirmed Raptor loss and mTORC1 inactivation in whole sWAT and pgWAT depots from the 12-week old mice ( Figure 2D ). The residual Raptor signal is from stromal vascular fraction (SVF) cells as Raptor is virtually undetectable in purified mature adipocytes ( Figure 2E ). Histological analysis of the white adipocytes from 12-week old Raptor Adipoq-cre mice revealed a heterogeneous size distribution pattern ( Figure 2F ). For example, pgWAT adipocytes in the Raptor Adipoqcre mice show a bimodal distribution in which the relative number of small (<100 mM) and large (>200 mM) adipocytes is significantly increased compared to controls ( Figure 2G ). The mutant sWAT also contains two populations of adipocytes: a pool of large unilocular adipocytes and a pool of smaller adipocytes containing multiple lipid droplets ( Figure 2F ). Thus, with age the Raptor Adipoq-cre mice also cannot maintain normal adipocyte morphology. Strikingly, at 12-weeks of age there is also a 46% increase in liver mass in the Raptor Adipoq-cre mice compared to controls that is associated with a paler color suggesting hepatic steatosis ( Figure 3A,B) . The overgrowth of non-adipose tissues is largely restricted to the liver as the mass of other lean tissues including the heart and skeletal muscles is unchanged ( Figure 3A) . We confirmed hepatic steatosis by Oil Red O staining, which revealed a marked increase in lipid staining in the KO ( Figure 3C ). Consistently, expression of the major de novo lipogenesis (DNL) enzymes ATP-citrate lyase (ACLY), Acetyl-CoA Carboxylase (ACC) and Fatty Acid Synthase (FASN) are also increased in Raptor Adipoq-cre KO livers ( Figure 3D ). Raptor Adipoq-cre KO mice are also insulin intolerant exhibiting a 54% increase in AUC in insulin tolerance tests ( Figure 3E, top) ; glucose tolerance is normal ( Figure 3E, bottom) . Serum chemistry analysis indicates normal circulating free fatty acids (FFAs) (p ¼ 0.77), but a trending increase in circulating triacylglycerides (TAGs) (p ¼ 0.0851) and cholesterol (p ¼ 0.067) ( Figure 3F ). Insulin levels are not significantly different ( Figure 3G ). We conclude that the progressive lipodystrophy in Raptor Adipoq-cre mice is causing systemic metabolic disease including insulin intolerance, hyperlipidemia, and non-alcoholic fatty liver disease (NAFLD).
Altered lipid metabolic pathways in adipocyte
Raptor KO mice The mTORC1 inhibitor rapamycin can stimulate lipolysis in cultured adipocytes [17, 18] . Therefore, we examined the major regulators of lipolysis in Raptor-deficient adipose tissues. We did not observe a significant increase in hormone sensitive lipase (HSL) phosphorylation between control and KO in pgWAT at 12 weeks of age; in fact it was slightly lower ( Figure 2D ). We also did not detect increased adipose triglyceride lipase (ATGL) protein levels in the sWAT of Raptor Adipoq-cre mice; however, we could detect a slight increase in ATGL in the pgWAT ( Figure 2D ) that correlated with a modest increase in basal glycerol release from tissue explants ( Figure 4A ). However, Atgl mRNA was decreased in both WAT depots ( Figure 4B ). Additionally, we examined regulators of lipogenesis. In the pgWAT of Raptor Adipoq-cre mice we detected significant increases in Acly (2.5 fold), Acc (2.1 fold), and Fasn (2.1 fold) mRNA ( Figure 4C left) and protein ( Figure 2D ). Similar increases occur in the sWAT although only the increase in Acly mRNA reaches significance even though ACLY, ACC and FASN proteins are all elevated in this depot ( Figures 2D, 4C right) . Consistently, expression of Chrebpb, which encodes an isoform of ChREBP that potently induces transcription of the DNL genes [19] , increases by 124-fold and 48-fold in pgWAT and sWAT respectively ( Figure 4D ). This is interesting because although DNL contributes only a fraction to the total lipid pool of adipocytes, increased Chrebpb expression and DNL often correlate with insulin sensitivity [19] indicating this can be uncoupled in the Raptor Adipoq-cre mice. Moreover, while the mTORC1 substrate ULK1 is well known to control autophagy, in mature adipocytes it may have an additional role in lipogenesis downstream of mTORC1 as in vitro knockdown of Ulk1 in differentiated 3T3L1 adipocytes increases Acc and Fasn expression [20] . Thus, in vivo Raptor loss in mature adipocytes alters the normal regulation of lipid metabolic pathways, possibly with depot-dependent variances.
3.4.
Raptor KO mice are resistant to diet-induced obesity but develop severe hepatic steatosis We next asked whether Raptor Adipoq-Cre mice could increase their fat mass if placed on an obesogenic high fat diet (HFD). Beginning at 12-weeks of age, Raptor Adipoq-Cre mice and their age matched controls were switched onto a HFD for 8-weeks. Controls gained on average 9.4 g of body weight while in contrast Raptor Adipoq-Cre mice gained only 2.5 g resulting in a 14% difference in total body mass between the two cohorts after 8 weeks ( Figure 5A ). Body composition analysis indicates the weight difference is due to a 5-fold decrease in fat mass in the mutants, which notably also have slightly higher lean mass ( Figure 5B) . The difference in fat mass is clearly evident upon dissection ( Figure 5C ) and individual tissue mass measurements ( Figure 5D ). Comparing the average mass of individual WAT depots at the start and end of HFD feeding shows that control sWAT increases by 5.9 fold and pgWAT by 6.5 fold while the mutant sWAT and pgWAT barely grow, increasing by only 1.9 fold and 1.3 fold, respectively ( Figure 5E ). Interestingly, comparing individual adipocyte size at the start and end of HFD feeding indicates that the control and KO adipocytes in both depots increase in size although the size heterogeneity in the KO tissue is still apparent ( Figure 5F ). Thus, despite the inability of whole Raptor KO depots to expand on HFD, Raptor KO adipocytes appear to retain some ability to grow by hypertrophy.
Importantly, at the conclusion of HFD-feeding, the livers of the KO mice are now w80% larger than controls (as opposed to 46% larger at the start of feeding) resulting in a liver/body weight ratio that is now nearly twice of that of controls ( Figure 5G,H,I ). The livers of the KO mice also exhibit significantly more severe hepatic steatosis ( Figure 5J ). Muscle and heart mass remain unchanged between the cohorts ( Figure 5G) . Thus, the inability of adipose tissues to expand in HFD-fed Raptor AdipoqCre mice results in more redistribution of lipids to the liver.
3.5. Adipocyte Raptor KO mice have normal energy expenditure and a lipid absorption defect Next we explored possible mechanisms by which deleting Raptor in adipocytes restricts adipose tissue growth. One possibility is that Raptor increases energy expenditure (EE), which protects against obesity. We reasoned that the severe hepatic steatosis and hepatomegaly observed in both chow and HFD fed Raptor Adipo-Cre cohorts argues against this scenario. However, the concept was previously proposed in a study that used aP2-Cre to delete Raptor in adipose tissue [12] . This study observed normal food intake but resistance to HFD and improved insulin tolerance in Raptor aP2-Cre mice and this was attributed to increased in Ucp1 mRNA expression in pgWAT and elevated EE; hepatic steatosis and hepatomegaly was not observed in Raptor aP2-Cre mice. Indeed, we find that Ucp1 mRNA is increased in both the sWAT and pgWAT of Raptor Adipo-Cre mice consuming chow diet ( Figure 6A ). This correlates with elevated Pgc1a levels in sWAT, and elevated Cpt1 in both sWAT and pgWAT ( Figure 6A ). However, in chow fed mice UCP1 protein was barely detectable in either WAT depot ( Figure 6B ). Moreover, we could only detect a slight increase in UCP1 protein in the sWAT of HFD-fed Raptor Adipo-Cre mice after a long exposure ( Figure 6B ). This suggests that total UCP1 protein is only slightly elevated in the sWAT of Raptor Adipo-Cre mice. To better assess energy balance we also performed metabolic cage experiments. We found no difference in EE between HFD-fed RaptorAdipoq-cre mice and controls when expressing the data "per mouse" as recommend in [16] (Figure 6C ). However, because it is often debated which method of reporting is correct, we provide the raw data in Table S1 . We also found that the Respiratory Exchange Ratio (RER) is higher in Raptor Adipoq-cre mice indicating greater utilization of carbohydrates for fuel ( Figure 6D ). Raptor Adipoq-cre mice also exhibited normal physical activity ( Figure 6E ) yet interestingly, they are hyperphagic consuming nearly twice as much food as controls ( Figure 6F ). Hyperphagia is likely explained by the fact that HFD-fed Raptor Adipoq-cre mice have greatly reduced circulating leptin ( Figure 6G ). We also examined fecal lipids and found nearly twice the amount of lipid in the feces of Raptor Adipoq-cre mice ( Figure 6H ) indicating a lipid absorption defect. Thus, the mechanism causing resistance to obesity in Raptor Adipoq-cre mice cannot be explained by decreased food intake or increased EE. Based on the increased EE reported in aP2-Cre;Raptor mice, it was suggested that adipose mTORC1 could be a potential target for antiobesity drugs. However, our results indicate several important phenotypic differences compared to Raptor aP2-Cre mice (see detailed comparison in Table S2 ). These differences likely reflect recent data indicating that the aP2-Cre driver has limited efficiency for adipocytes and targets non-adipocytes such as endothelial cells [7e11] . It would be interesting to identify the exact target cell/mechanism responsible for the beneficial metabolic effects of deleting Raptor with aP2-Cre. Nevertheless, in light of our characterization of Raptor Adipoq-Cre mice, we would argue against prolonged targeting of mTORC1 in fat as a strategy to reduce obesity, though the effects of temporal or partial mTORC1 loss have not been thoroughly explored.
3.6. Decreased C/EBPa activity in Raptor-deficient WAT We next asked whether adipocytes require mTORC1 to maintain expression of Pparg, which encodes the master transcriptional regulator of adipocyte differentiation and function, and is a marker of adipocyte identity. We saw no significant changes in Pparg mRNA expression in the sWAT or pgWAT from Raptor Adipoq-Cre mice eating chow or HFD ( Figure 6I ) suggesting Raptor is not required to maintain adipocyte identity per se. We also examined the expression of CD36 and Lpl, two Pparg targets. In chow fed mice, Lpl tended to be lower while CD36 unaffected ( Figure 6J ); in the HFD group, both genes are reduced ( Figure 6J ). Thus, Pparg activity, particularly during high fat feeding, may be altered in Raptor KO adipocytes. In contrast to Pparg, expression of the Pparg co-regulator C/EBPa (the founding member of the CCAAT/enhancer-binding family) is greatly reduced in the sWAT of both chow and HFD-fed mice as well as in pgWAT, though to a lesser extent in this depot ( Figure 6K ). Interestingly, it was recently reported that C/EBPa in mature adipocytes is dispensable for terminal embryonic adipogenesis and adult adipocyte survival, but required for normal adipose tissue expansion during high fat diet feeding [21] . C/EBPa also promotes adiponectin expression [22e24]. Indeed, adiponectin mRNA expression in WAT ( Figure 6L ) and circulating Adiponectin levels ( Figure 3H ) are greatly reduced in Raptor Adipoq-Cre mice. Thus, decreased C/EBPa activity provides a possible mechanism to explain why only older Raptor Adipoq-Cre mice are resistant to adipose tissue expansion.
Comparison to human lipodystrophy Raptor
Adipoq-Cre mice bear phenotypic resemblance to human patients suffering from congenital generalized lipodystrophy or BerardinelliSeip lipodystrophy [25] . These patients suffer from adipose tissue loss, and similar to the Raptor Adipoq-Cre model, exhibit insulin resistance, hepatic steatosis, hypertriglyceridemia, and increased RER. Nearly a quarter of the patients develop diabetes mellitus. Other clinical features can include ectopic lipid in muscle and hypertrophic cardiomyopathy. Berardinelli-Seip lipodystrophy is linked to mutations in AGPAT2 or BSCL2/seipin but the molecular basis of the disease is poorly understood. Interestingly, AGPAT2 and BSCL2 knockout models exhibit several phenotypic similarities to Raptor Adipoq-Cre mice [26e28]. Moreover, the mTORC1 substrate Lipin-1, a phosphatidic acid phosphatase mutated in fatty liver dystrophy (fld) mice, was recently shown to physically interact with Seipin and AGPAT2 [29e31]. Thus, Raptor Adipoq-Cre mice may be useful in understanding the mechanistic basis of human congenital lipodystrophy.
CONCLUSIONS
In this study we investigated the in vivo role of mTORC1 in mature adipocytes by deleting Raptor with Adiponectin-Cre. We conclude that mTORC1 activity in white adipocytes is dispensable for early post-natal WAT growth, but becomes essential for normal adipose tissue expansion with age. Moreover, adipocyte Raptor KO mice consuming a high fat diet are hyperphagic yet resistant to obesity. However, despite increased Ucp1 mRNA expression in WAT, these mice are not protected from obesity due to increased energy expenditure. Rather, they appear to have a defect in adipose tissue expansion, which redistributes lipids to the liver resulting in severe hepatomegaly and hepatic steatosis, and causes a dietary lipid absorption defect. It does not appear that mTORC1 activity is required in WAT to maintain Pparg expression, but it may promote PPARg activity towards certain targets. We also find that mTORC1 is required for normal C/ebpa and adiponectin expression providing a plausible link to the adipose tissue expansion defect in older mice.
We found no obvious indication that adipocytes were dying in large numbers (i.e. crown-like structures) at least at the time-points examined. One hypothesis is that increased autophagy coupled with defective lipid metabolic pathways, perhaps in part through altered ULK1 and/or Lipin function, could cause defective triglyceride accumulation and/or adipose tissue wasting. Alternatively, mTORC1 in mature adipocytes may promote WAT expansion in older mice by regulating production of a pro-adipogenic paracrine signal. Interestingly, mTORC1 may have a unique function in neo-natal BAT development that requires further examination. Because mTORC1 has several known and putative substrates [32, 33] it will be important to continue delineating the expression and contributions of each downstream pathway in WAT maintenance in vivo using the most updated and precise genetic and metabolic strategies. We also found that mTORC1 loss did not impair the post-natal BAT-like character of sWAT. Interestingly, it was recently reported that rapamycin blocks the "browning" of WAT in adult mice by inhibiting mTORC1 in mature adipocytes [34, 35] suggesting there may be differential requirements for mTORC1 in post-natal versus adult brite/ beige adipocyte formation. Moreover, another study reported that increased mTORC1 signaling in BAT promotes a brown-to-white phenotypic switch, and in this model, rapamycin reversed the "whitening" of BAT [36] . Thus, the precise role of mTORC1 in BAT/WAT interconversions remains to be seen. Notably, our conclusions are based on chronic (congenital) Raptor loss in adipocytes and thus the primary in vivo defect associated with losing mTORC1 activity cannot be determined by this approach. Moreover, it is clearly difficult to obtain the perfect Cre-driver for tissue-specific KO studies, thus future advances may lead to additional refinements in understanding mTORC1 signaling in fat. Nevertheless, Raptor Adipoq-Cre mice exhibit phenotypic similarities to human patients suffering from congenital generalized lipodystrophy suggesting this model may have significant clinical implications.
